Format

Send to

Choose Destination
J Virus Erad. 2017 Jan 1;3(1):56-60.

Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception.

Author information

1
HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT) , Bangkok , Thailand.
2
Chiang Rai Prachanukroh Hospital , Chiang Rai , Thailand.
3
Faculty of Medicine , Khon Kaen University , Khon Kaen , Thailand.
4
Phra Chomklao Hospital Hospital , Phetchaburi , Thailand.
5
Phrapokklao Hospital , Chanthaburi , Thailand.
6
HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand; Department of Global Health, University of Amsterdam, Amsterdam Institute for Global Health and Development, the Netherlands.
7
HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand; SEARCH, Thai Red Cross AIDS Research Centre, Bangkok, Thailand; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.

Abstract

BACKGROUND:

Little is known about the cumulative effect of HIV antiretroviral therapy (ART) and hormonal contraception (HC) on metabolism and inflammation in HIV-positive women.

METHODS:

We conducted a cross-sectional assessment of markers for carbohydrate, lipid, bone metabolism, inflammation and coagulation in HIV-positive adolescents on ART and HC (n=37) versus on ART only (n=51) in Thailand. The Wilcoxon rank-sum test was used to assess differences between groups.

RESULTS:

The median age was 19.5 years. Most adolescents (95%) were perinatally infected. All were on ART for a median of 9 years. HC used was progestin only (n=21); combined oral contraceptive (COC) tablets (n=6) for the whole study period or alternating between progestin only and COC (n=10). Prevalence of any metabolic abnormalities was 99%. Four biomarkers were significantly higher with HC vs no HC: insulin (10.3 vs 6.2 μU/mL, P=0.002), insulin resistance (1.89 vs 1.19 mass units, P=0.005), 25-OH vitamin D (33.2 vs 20.2 ng/mL, P<0.0001) and C-terminal telopeptide (690 vs 530 ng/L, P=0.011). Triglycerides and D-dimer were significantly lower with HC (103 vs 139 mg/dL, P=0.014 and 140 vs 155 ng/mL, P=0.003, respectively). There was no relationship between the type of HC or ART and the above differences.

CONCLUSION:

Perinatally infected HIV-positive adolescents on ART in this pilot study had a high prevalence of metabolic abnormalities. Bone turnover markers and insulin resistance were significantly higher with HC. Research on the cumulative effect of HIV, ART and HC on metabolism and inflammation in adolescents with HIV is important in order to devise strategies for preventing and mitigating long-term comorbidities.

PMID:
28275459
PMCID:
PMC5337422

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center